Post by Regeneron
671,943 followers
What if human genetics could help reduce uncertainty earlier in drug discovery? Aris Baras, Head of Regeneron Genetics Center (RGC), joined Daniel Levine on Levine Media Group's The Bio Report to dig into one of drug discovery’s hardest problems: choosing the right targets to pursue. In the conversation, Aris breaks down how RGC pairs large-scale human genetics with clinical data and AI-driven analytics to find and prioritize promising targets earlier, pointing to research toward the opportunities most likely to matter to patients. Hear more about how RGC is working to clear the target bottleneck in drug discovery: https://bit.ly/4vQjj12 #GeneticResearch #Genetics #BioTech
Video Content